The fact that lenacapavir will soon be available to patients is a testament to the strength of America's biopharmaceutical ...

GSK specialty medicines grew YoY in Q1 2025, and it is now the main profit engine, offsetting the weakness in their vaccine ...

Nearly 12 million people could lose health care coverage if the bill gets passed and signed by Trump, while hospitals would be hit hard by Medicaid cuts.

HealthLink talked with a Seattle-based physician about why the newly approved drug could be a game-changer in preventing HIV.

The United States Food and Drug Administration has approved lenacapavir, an injectable drug that offers long-lasting ...

A newly approved HIV medication provides near-total protection against infection with just two injections a year. It's called Lenacapavir. But the high price of the drug could limit its reach.